Pacira Biosciences Inc at RBC Capital Markets Global Healthcare Conference Transcript
So, for our next group setting here, we have Pacira Biosciences, and it's our pleasure to have Shawn Cross, the Chief Financial Officer, joining us today. Thank you for attending. Yeah, you bet.
Questions & Answers
So I wanted to start off, no surprise, with a number of questions on EXPAREL, the franchise, what's going on in the market. And maybe I could first start off with when you look at Q1 2026, we had volume growth of around 7%, revenue growth was around 5%, and I know we're just about to lap that third GPO. I think you've indicated sometime this summer.
Can you talk about that volume to revenue gap and how that may change as we enter the second half of the year and the implications for the company?
Sure, absolutely. So this is, as you would imagine, it's a question we get frequently. And just a reminder and a step back over the past 18 months or so, to really take advantage of the spark of the
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
